2030 Drug Development Pharmaceuticals 
Drug Patent Watch
DECEMBER 10, 2024
The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48
Drug Patent Watch
DECEMBER 11, 2024
The pharmaceutical industry, particularly the generic drug sector, faces significant challenges in adopting sustainable practices. This article outlines key considerations and strategies for developing a sustainable generic drug development strategy. “Generics are known for their cost-effectiveness.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
DrugBank
AUGUST 9, 2024
Investment Trends in Pharmaceutical Research and Development Investing in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more detail. The average cost of bringing a new drug to market is about $2.6 reported in 2021. trillion by 2028.
DrugBank
MARCH 7, 2024
The landscape of weight loss drugs has been rapidly evolving, and 2024 is poised to be another transformative year in this market. Pharmaceutical researchers, in particular, have a keen interest in understanding the unfolding dynamics of this market. Let’s delve into what lies ahead in the coming year.
PPD
OCTOBER 18, 2023
There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care. Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030.
DrugBank
NOVEMBER 4, 2024
The pharmaceutical industry is the primary source of antibiotic innovation; therefore, it must lead the way in combating resistance. trillion loss in GDP by 2030 shows the urgency of this crisis. This costly, high-risk development pipeline has high attrition rates and uncertain market returns.
Codon
NOVEMBER 3, 2024
But they will need to do so if they want to meet the goals set out by the End TB Strategy , namely, to reduce TB cases by 80 percent and curb deaths by 90 percent before 2030. As an undergraduate biology student, I spent some time in a TB lab working on antibiotic resistance — a growing concern for drug developers.
Expert insights. Personalized for you.
96 
Let's personalize your content